Global NK Cell Therapy Market Growth 2018-2023

October 2018 | 138 pages | ID: GC82D936766EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global NK Cell Therapy market for 2018-2023.

Over the next five years, LPI(LP Information) projects that NK Cell Therapy will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of NK Cell Therapy market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Mogamulizumab
• Lorvotuzumab Mertansine
• Others

Segmentation by application:

• Cancer
• Cardiovascular Diseases
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Chipscreen Biosciences (China)
• Affimed NV (Netherlands)
• Altor BioScience Corporation (USA)
• Innate Pharma SA (France)
• Takeda Pharmaceutical (Japan)
• Sorrento Therapeutics Inc. (USA)
• NantKwest Inc. (USA)
• Bristol-Myers Squibb (USA)
• NKT Therapeutics (USA)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global NK Cell Therapy consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of NK Cell Therapy market by identifying its various subsegments.
• Focuses on the key global NK Cell Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the NK Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of NK Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global NK Cell Therapy Consumption 2013-2023
  2.1.2 NK Cell Therapy Consumption CAGR by Region
2.2 NK Cell Therapy Segment by Type
  2.2.1 Mogamulizumab
  2.2.2 Lorvotuzumab Mertansine
  2.2.3 Others
2.3 NK Cell Therapy Consumption by Type
  2.3.1 Global NK Cell Therapy Consumption Market Share by Type (2013-2018)
  2.3.2 Global NK Cell Therapy Revenue and Market Share by Type (2013-2018)
  2.3.3 Global NK Cell Therapy Sale Price by Type (2013-2018)
2.4 NK Cell Therapy Segment by Application
  2.4.1 Cancer
  2.4.2 Cardiovascular Diseases
  2.4.3 Others
2.5 NK Cell Therapy Consumption by Application
  2.5.1 Global NK Cell Therapy Consumption Market Share by Application (2013-2018)
  2.5.2 Global NK Cell Therapy Value and Market Share by Application (2013-2018)
  2.5.3 Global NK Cell Therapy Sale Price by Application (2013-2018)

3 GLOBAL NK CELL THERAPY BY PLAYERS

3.1 Global NK Cell Therapy Sales Market Share by Players
  3.1.1 Global NK Cell Therapy Sales by Players (2016-2018)
  3.1.2 Global NK Cell Therapy Sales Market Share by Players (2016-2018)
3.2 Global NK Cell Therapy Revenue Market Share by Players
  3.2.1 Global NK Cell Therapy Revenue by Players (2016-2018)
  3.2.2 Global NK Cell Therapy Revenue Market Share by Players (2016-2018)
3.3 Global NK Cell Therapy Sale Price by Players
3.4 Global NK Cell Therapy Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global NK Cell Therapy Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players NK Cell Therapy Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 NK CELL THERAPY BY REGIONS

4.1 NK Cell Therapy by Regions
  4.1.1 Global NK Cell Therapy Consumption by Regions
  4.1.2 Global NK Cell Therapy Value by Regions
4.2 Americas NK Cell Therapy Consumption Growth
4.3 APAC NK Cell Therapy Consumption Growth
4.4 Europe NK Cell Therapy Consumption Growth
4.5 Middle East & Africa NK Cell Therapy Consumption Growth

5 AMERICAS

5.1 Americas NK Cell Therapy Consumption by Countries
  5.1.1 Americas NK Cell Therapy Consumption by Countries (2013-2018)
  5.1.2 Americas NK Cell Therapy Value by Countries (2013-2018)
5.2 Americas NK Cell Therapy Consumption by Type
5.3 Americas NK Cell Therapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC NK Cell Therapy Consumption by Countries
  6.1.1 APAC NK Cell Therapy Consumption by Countries (2013-2018)
  6.1.2 APAC NK Cell Therapy Value by Countries (2013-2018)
6.2 APAC NK Cell Therapy Consumption by Type
6.3 APAC NK Cell Therapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe NK Cell Therapy by Countries
  7.1.1 Europe NK Cell Therapy Consumption by Countries (2013-2018)
  7.1.2 Europe NK Cell Therapy Value by Countries (2013-2018)
7.2 Europe NK Cell Therapy Consumption by Type
7.3 Europe NK Cell Therapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa NK Cell Therapy by Countries
  8.1.1 Middle East & Africa NK Cell Therapy Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa NK Cell Therapy Value by Countries (2013-2018)
8.2 Middle East & Africa NK Cell Therapy Consumption by Type
8.3 Middle East & Africa NK Cell Therapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 NK Cell Therapy Distributors
10.3 NK Cell Therapy Customer

11 GLOBAL NK CELL THERAPY MARKET FORECAST

11.1 Global NK Cell Therapy Consumption Forecast (2018-2023)
11.2 Global NK Cell Therapy Forecast by Regions
  11.2.1 Global NK Cell Therapy Forecast by Regions (2018-2023)
  11.2.2 Global NK Cell Therapy Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global NK Cell Therapy Forecast by Type
11.8 Global NK Cell Therapy Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Chipscreen Biosciences (China)
  12.1.1 Company Details
  12.1.2 NK Cell Therapy Product Offered
  12.1.3 Chipscreen Biosciences (China) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Chipscreen Biosciences (China) News
12.2 Affimed NV (Netherlands)
  12.2.1 Company Details
  12.2.2 NK Cell Therapy Product Offered
  12.2.3 Affimed NV (Netherlands) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Affimed NV (Netherlands) News
12.3 Altor BioScience Corporation (USA)
  12.3.1 Company Details
  12.3.2 NK Cell Therapy Product Offered
  12.3.3 Altor BioScience Corporation (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Altor BioScience Corporation (USA) News
12.4 Innate Pharma SA (France)
  12.4.1 Company Details
  12.4.2 NK Cell Therapy Product Offered
  12.4.3 Innate Pharma SA (France) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Innate Pharma SA (France) News
12.5 Takeda Pharmaceutical (Japan)
  12.5.1 Company Details
  12.5.2 NK Cell Therapy Product Offered
  12.5.3 Takeda Pharmaceutical (Japan) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Takeda Pharmaceutical (Japan) News
12.6 Sorrento Therapeutics Inc. (USA)
  12.6.1 Company Details
  12.6.2 NK Cell Therapy Product Offered
  12.6.3 Sorrento Therapeutics Inc. (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Sorrento Therapeutics Inc. (USA) News
12.7 NantKwest Inc. (USA)
  12.7.1 Company Details
  12.7.2 NK Cell Therapy Product Offered
  12.7.3 NantKwest Inc. (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 NantKwest Inc. (USA) News
12.8 Bristol-Myers Squibb (USA)
  12.8.1 Company Details
  12.8.2 NK Cell Therapy Product Offered
  12.8.3 Bristol-Myers Squibb (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Bristol-Myers Squibb (USA) News
12.9 NKT Therapeutics (USA)
  12.9.1 Company Details
  12.9.2 NK Cell Therapy Product Offered
  12.9.3 NKT Therapeutics (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 NKT Therapeutics (USA) News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of NK Cell Therapy
Table Product Specifications of NK Cell Therapy
Figure NK Cell Therapy Report Years Considered
Figure Market Research Methodology
Figure Global NK Cell Therapy Consumption Growth Rate 2013-2023 (K Units)
Figure Global NK Cell Therapy Value Growth Rate 2013-2023 ($ Millions)
Table NK Cell Therapy Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Mogamulizumab
Table Major Players of Mogamulizumab
Figure Product Picture of Lorvotuzumab Mertansine
Table Major Players of Lorvotuzumab Mertansine
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global NK Cell Therapy Consumption Market Share by Type (2013-2018)
Figure Global NK Cell Therapy Consumption Market Share by Type (2013-2018)
Table Global NK Cell Therapy Revenue by Type (2013-2018) ($ million)
Table Global NK Cell Therapy Value Market Share by Type (2013-2018) ($ Millions)
Figure Global NK Cell Therapy Value Market Share by Type (2013-2018)
Table Global NK Cell Therapy Sale Price by Type (2013-2018)
Figure NK Cell Therapy Consumed in Cancer
Figure Global NK Cell Therapy Market: Cancer (2013-2018) (K Units)
Figure Global NK Cell Therapy Market: Cancer (2013-2018) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure NK Cell Therapy Consumed in Cardiovascular Diseases
Figure Global NK Cell Therapy Market: Cardiovascular Diseases (2013-2018) (K Units)
Figure Global NK Cell Therapy Market: Cardiovascular Diseases (2013-2018) ($ Millions)
Figure Global Cardiovascular Diseases YoY Growth ($ Millions)
Figure NK Cell Therapy Consumed in Others
Figure Global NK Cell Therapy Market: Others (2013-2018) (K Units)
Figure Global NK Cell Therapy Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global NK Cell Therapy Consumption Market Share by Application (2013-2018)
Figure Global NK Cell Therapy Consumption Market Share by Application (2013-2018)
Table Global NK Cell Therapy Value by Application (2013-2018)
Table Global NK Cell Therapy Value Market Share by Application (2013-2018)
Figure Global NK Cell Therapy Value Market Share by Application (2013-2018)
Table Global NK Cell Therapy Sale Price by Application (2013-2018)
Table Global NK Cell Therapy Sales by Players (2016-2018) (K Units)
Table Global NK Cell Therapy Sales Market Share by Players (2016-2018)
Figure Global NK Cell Therapy Sales Market Share by Players in 2016
Figure Global NK Cell Therapy Sales Market Share by Players in 2017
Table Global NK Cell Therapy Revenue by Players (2016-2018) ($ Millions)
Table Global NK Cell Therapy Revenue Market Share by Players (2016-2018)
Figure Global NK Cell Therapy Revenue Market Share by Players in 2016
Figure Global NK Cell Therapy Revenue Market Share by Players in 2017
Table Global NK Cell Therapy Sale Price by Players (2016-2018)
Figure Global NK Cell Therapy Sale Price by Players in 2017
Table Global NK Cell Therapy Manufacturing Base Distribution and Sales Area by Players
Table Players NK Cell Therapy Products Offered
Table NK Cell Therapy Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global NK Cell Therapy Consumption by Regions 2013-2018 (K Units)
Table Global NK Cell Therapy Consumption Market Share by Regions 2013-2018
Figure Global NK Cell Therapy Consumption Market Share by Regions 2013-2018
Table Global NK Cell Therapy Value by Regions 2013-2018 ($ Millions)
Table Global NK Cell Therapy Value Market Share by Regions 2013-2018
Figure Global NK Cell Therapy Value Market Share by Regions 2013-2018
Figure Americas NK Cell Therapy Consumption 2013-2018 (K Units)
Figure Americas NK Cell Therapy Value 2013-2018 ($ Millions)
Figure APAC NK Cell Therapy Consumption 2013-2018 (K Units)
Figure APAC NK Cell Therapy Value 2013-2018 ($ Millions)
Figure Europe NK Cell Therapy Consumption 2013-2018 (K Units)
Figure Europe NK Cell Therapy Value 2013-2018 ($ Millions)
Figure Middle East & Africa NK Cell Therapy Consumption 2013-2018 (K Units)
Figure Middle East & Africa NK Cell Therapy Value 2013-2018 ($ Millions)
Table Americas NK Cell Therapy Consumption by Countries (2013-2018) (K Units)
Table Americas NK Cell Therapy Consumption Market Share by Countries (2013-2018)
Figure Americas NK Cell Therapy Consumption Market Share by Countries in 2017
Table Americas NK Cell Therapy Value by Countries (2013-2018) ($ Millions)
Table Americas NK Cell Therapy Value Market Share by Countries (2013-2018)
Figure Americas NK Cell Therapy Value Market Share by Countries in 2017
Table Americas NK Cell Therapy Consumption by Type (2013-2018) (K Units)
Table Americas NK Cell Therapy Consumption Market Share by Type (2013-2018)
Figure Americas NK Cell Therapy Consumption Market Share by Type in 2017
Table Americas NK Cell Therapy Consumption by Application (2013-2018) (K Units)
Table Americas NK Cell Therapy Consumption Market Share by Application (2013-2018)
Figure Americas NK Cell Therapy Consumption Market Share by Application in 2017
Figure United States NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure United States NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Canada NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Canada NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Mexico NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Mexico NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Table APAC NK Cell Therapy Consumption by Countries (2013-2018) (K Units)
Table APAC NK Cell Therapy Consumption Market Share by Countries (2013-2018)
Figure APAC NK Cell Therapy Consumption Market Share by Countries in 2017
Table APAC NK Cell Therapy Value by Countries (2013-2018) ($ Millions)
Table APAC NK Cell Therapy Value Market Share by Countries (2013-2018)
Figure APAC NK Cell Therapy Value Market Share by Countries in 2017
Table APAC NK Cell Therapy Consumption by Type (2013-2018) (K Units)
Table APAC NK Cell Therapy Consumption Market Share by Type (2013-2018)
Figure APAC NK Cell Therapy Consumption Market Share by Type in 2017
Table APAC NK Cell Therapy Consumption by Application (2013-2018) (K Units)
Table APAC NK Cell Therapy Consumption Market Share by Application (2013-2018)
Figure APAC NK Cell Therapy Consumption Market Share by Application in 2017
Figure China NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure China NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Japan NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Japan NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Korea NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Korea NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure India NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure India NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Australia NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Australia NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Table Europe NK Cell Therapy Consumption by Countries (2013-2018) (K Units)
Table Europe NK Cell Therapy Consumption Market Share by Countries (2013-2018)
Figure Europe NK Cell Therapy Consumption Market Share by Countries in 2017
Table Europe NK Cell Therapy Value by Countries (2013-2018) ($ Millions)
Table Europe NK Cell Therapy Value Market Share by Countries (2013-2018)
Figure Europe NK Cell Therapy Value Market Share by Countries in 2017
Table Europe NK Cell Therapy Consumption by Type (2013-2018) (K Units)
Table Europe NK Cell Therapy Consumption Market Share by Type (2013-2018)
Figure Europe NK Cell Therapy Consumption Market Share by Type in 2017
Table Europe NK Cell Therapy Consumption by Application (2013-2018) (K Units)
Table Europe NK Cell Therapy Consumption Market Share by Application (2013-2018)
Figure Europe NK Cell Therapy Consumption Market Share by Application in 2017
Figure Germany NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Germany NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure France NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure France NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure UK NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure UK NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Italy NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Italy NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Russia NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Russia NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Spain NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Spain NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa NK Cell Therapy Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa NK Cell Therapy Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa NK Cell Therapy Consumption Market Share by Countries in 2017
Table Middle East & Africa NK Cell Therapy Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa NK Cell Therapy Value Market Share by Countries (2013-2018)
Figure Middle East & Africa NK Cell Therapy Value Market Share by Countries in 2017
Table Middle East & Africa NK Cell Therapy Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa NK Cell Therapy Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa NK Cell Therapy Consumption Market Share by Type in 2017
Table Middle East & Africa NK Cell Therapy Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa NK Cell Therapy Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa NK Cell Therapy Consumption Market Share by Application in 2017
Figure Egypt NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Egypt NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure South Africa NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure South Africa NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Israel NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Israel NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure Turkey NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure Turkey NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Figure GCC Countries NK Cell Therapy Consumption Growth 2013-2018 (K Units)
Figure GCC Countries NK Cell Therapy Value Growth 2013-2018 ($ Millions)
Table NK Cell Therapy Distributors List
Table NK Cell Therapy Customer List
Figure Global NK Cell Therapy Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global NK Cell Therapy Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global NK Cell Therapy Consumption Forecast by Countries (2018-2023) (K Units)
Table Global NK Cell Therapy Consumption Market Forecast by Regions
Table Global NK Cell Therapy Value Forecast by Countries (2018-2023) ($ Millions)
Table Global NK Cell Therapy Value Market Share Forecast by Regions
Figure Americas NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Americas NK Cell Therapy Value 2018-2023 ($ Millions)
Figure APAC NK Cell Therapy Consumption 2018-2023 (K Units)
Figure APAC NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Europe NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Europe NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Middle East & Africa NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Middle East & Africa NK Cell Therapy Value 2018-2023 ($ Millions)
Figure United States NK Cell Therapy Consumption 2018-2023 (K Units)
Figure United States NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Canada NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Canada NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Mexico NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Mexico NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Brazil NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Brazil NK Cell Therapy Value 2018-2023 ($ Millions)
Figure China NK Cell Therapy Consumption 2018-2023 (K Units)
Figure China NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Japan NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Japan NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Korea NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Korea NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Southeast Asia NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Southeast Asia NK Cell Therapy Value 2018-2023 ($ Millions)
Figure India NK Cell Therapy Consumption 2018-2023 (K Units)
Figure India NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Australia NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Australia NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Germany NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Germany NK Cell Therapy Value 2018-2023 ($ Millions)
Figure France NK Cell Therapy Consumption 2018-2023 (K Units)
Figure France NK Cell Therapy Value 2018-2023 ($ Millions)
Figure UK NK Cell Therapy Consumption 2018-2023 (K Units)
Figure UK NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Italy NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Italy NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Russia NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Russia NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Spain NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Spain NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Egypt NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Egypt NK Cell Therapy Value 2018-2023 ($ Millions)
Figure South Africa NK Cell Therapy Consumption 2018-2023 (K Units)
Figure South Africa NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Israel NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Israel NK Cell Therapy Value 2018-2023 ($ Millions)
Figure Turkey NK Cell Therapy Consumption 2018-2023 (K Units)
Figure Turkey NK Cell Therapy Value 2018-2023 ($ Millions)
Figure GCC Countries NK Cell Therapy Consumption 2018-2023 (K Units)
Figure GCC Countries NK Cell Therapy Value 2018-2023 ($ Millions)
Table Global NK Cell Therapy Consumption Forecast by Type (2018-2023) (K Units)
Table Global NK Cell Therapy Consumption Market Share Forecast by Type (2018-2023)
Table Global NK Cell Therapy Value Forecast by Type (2018-2023) ($ Millions)
Table Global NK Cell Therapy Value Market Share Forecast by Type (2018-2023)
Table Global NK Cell Therapy Consumption Forecast by Application (2018-2023) (K Units)
Table Global NK Cell Therapy Consumption Market Share Forecast by Application (2018-2023)
Table Global NK Cell Therapy Value Forecast by Application (2018-2023) ($ Millions)
Table Global NK Cell Therapy Value Market Share Forecast by Application (2018-2023)
Table Chipscreen Biosciences (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chipscreen Biosciences (China) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Chipscreen Biosciences (China) NK Cell Therapy Market Share (2016-2018)
Table Affimed NV (Netherlands) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Affimed NV (Netherlands) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Affimed NV (Netherlands) NK Cell Therapy Market Share (2016-2018)
Table Altor BioScience Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Altor BioScience Corporation (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Altor BioScience Corporation (USA) NK Cell Therapy Market Share (2016-2018)
Table Innate Pharma SA (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Innate Pharma SA (France) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Innate Pharma SA (France) NK Cell Therapy Market Share (2016-2018)
Table Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical (Japan) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Pharmaceutical (Japan) NK Cell Therapy Market Share (2016-2018)
Table Sorrento Therapeutics Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sorrento Therapeutics Inc. (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sorrento Therapeutics Inc. (USA) NK Cell Therapy Market Share (2016-2018)
Table NantKwest Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NantKwest Inc. (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure NantKwest Inc. (USA) NK Cell Therapy Market Share (2016-2018)
Table Bristol-Myers Squibb (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb (USA) NK Cell Therapy Market Share (2016-2018)
Table NKT Therapeutics (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NKT Therapeutics (USA) NK Cell Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure NKT Therapeutics (USA) NK Cell Therapy Market Share (2016-2018)